Early in 2010, a study showed that in four liver cancer cell lines (HuH6, Hep3B, HepG2, and HLE) down-regulation of TLE1 promoted tumorigenesis, suggesting that TLE1 may act as a tumor suppressor in hepatocellular carcinoma [43]. Here, TLE1 is linked to neoplasm.